68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

NCT02488070 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Prostate Carcinoma

Interventions

PROCEDURE: Computed Tomography
DRUG: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

Stanford University

Collaborators

[object Object]